Cargando…

Microbiome and Metabolomics in Liver Cancer: Scientific Technology

Primary liver cancer is a heterogeneous disease. Liver cancer metabolism includes both the reprogramming of intracellular metabolism to enable cancer cells to proliferate inappropriately and adapt to the tumor microenvironment and fluctuations in regular tissue metabolism. Currently, metabolomics an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ganesan, Raja, Yoon, Sang Jun, Suk, Ki Tae
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820585/ https://www.ncbi.nlm.nih.gov/pubmed/36613980 http://dx.doi.org/10.3390/ijms24010537

Ejemplares similares

Microbiome and metabolomics in alcoholic liver disease
por: Ganesan, Raja, et al.
Publicado: (2022)

Recent Advances of Microbiome-Associated Metabolomics Profiling in Liver Disease: Principles, Mechanisms, and Applications
por: Raja, Ganesan, et al.
Publicado: (2021)

Microbiome-Based Metabolic Therapeutic Approaches in Alcoholic Liver Disease
por: Hyun, Ji Ye, et al.
Publicado: (2022)

The juxtaposition of Ilex cornuta fruit and gut microbiota against alcoholic liver disease based on the integrated pharmacology via metabolomics
por: Oh, Ki‐Kwang, et al.
Publicado: (2023)

The Role of the Gut Microbiome in Liver Cirrhosis Treatment
por: Lee, Na Young, et al.
Publicado: (2020)

Carbon Nanotubes Induce Metabolomic Profile Disturbances in Zebrafish: NMR-Based Metabolomics Platform
por: Ganesan, Raja, et al.
Publicado: (2021)

Gut Microbiome in Non-Alcoholic Fatty Liver Disease: From Mechanisms to Therapeutic Role
por: Gupta, Haripriya, et al.
Publicado: (2022)

Pathophysiological Roles of Mucosal-Associated Invariant T Cells in the Context of Gut Microbiota-Liver Axis
por: Gebru, Yoseph Asmelash, et al.
Publicado: (2021)

Recent Trends of Microbiota-Based Microbial Metabolites Metabolism in Liver Disease
por: Ganesan, Raja, et al.
Publicado: (2022)

Lactobacillus lactis and Pediococcus pentosaceus‐driven reprogramming of gut microbiome and metabolome ameliorates the progression of non‐alcoholic fatty liver disease
por: Yu, Jeong Seok, et al.
Publicado: (2021)

Identification of Gut Microbiome Metabolites via Network Pharmacology Analysis in Treating Alcoholic Liver Disease
por: Oh, Ki-Kwang, et al.
Publicado: (2022)

Metabolomics-Microbiome Crosstalk in the Breast Cancer Microenvironment
por: Al-Ansari, Mysoon M., et al.
Publicado: (2021)

The Gut Microbiota-Derived Immune Response in Chronic Liver Disease
por: Won, Sung-Min, et al.
Publicado: (2021)

Food and Gut Microbiota-Derived Metabolites in Nonalcoholic Fatty Liver Disease
por: Jeong, Min Kyo, et al.
Publicado: (2022)

Gut Microbiota-Related Cellular and Molecular Mechanisms in the Progression of Nonalcoholic Fatty Liver Disease
por: Park, Eunju, et al.
Publicado: (2021)

The convergent application of metabolites from Avena sativa and gut microbiota to ameliorate non-alcoholic fatty liver disease: a network pharmacology study
por: Oh, Ki-Kwang, et al.
Publicado: (2023)

The Microbiome in Autoimmune Liver Diseases: Metagenomic and Metabolomic Changes
por: Zheng, Yanping, et al.
Publicado: (2021)

Microbiome, Metabolome and Inflammatory Bowel Disease
por: Ahmed, Ishfaq, et al.
Publicado: (2016)

Metabolome–Microbiome Crosstalk and Human Disease
por: Lee-Sarwar, Kathleen A., et al.
Publicado: (2020)

Nutritional Status and Diet Style Affect Cognitive Function in Alcoholic Liver Disease
por: Choi, Ye Rin, et al.
Publicado: (2021)

The Role of the Microbiome in Liver Cancer
por: Moreno-Gonzalez, Mar, et al.
Publicado: (2021)

Microbiome—Microbial Metabolome—Cancer Cell Interactions in Breast Cancer—Familiar, but Unexplored
por: Mikó, Edit, et al.
Publicado: (2019)

Metagenomics, Metatranscriptomics, and Metabolomics Approaches for Microbiome Analysis
por: Aguiar-Pulido, Vanessa, et al.
Publicado: (2016)

Computational Approaches for Integrative Analysis of the Metabolome and Microbiome
por: Chong, Jasmine, et al.
Publicado: (2017)

Microcellular Environmental Regulation of Silver Nanoparticles in Cancer Therapy: A Critical Review
por: Raja, Ganesan, et al.
Publicado: (2020)

The implementation of omics technologies in cancer microbiome research
por: Mullish, Benjamin H, et al.
Publicado: (2018)

The Lactobacillus as a Probiotic: Focusing on Liver Diseases
por: Jeong, Jin-Ju, et al.
Publicado: (2022)

Scientific technology and social change. Readings from `Scientific American'
Publicado: (1977)

Exploring the diversity of blood microbiome during liver diseases: Unveiling Novel diagnostic and therapeutic Avenues
por: Vasudevan, Dinakaran, et al.
Publicado: (2023)

A Systematic Role of Metabolomics, Metabolic Pathways, and Chemical Metabolism in Lung Cancer
por: Kannampuzha, Sandra, et al.
Publicado: (2023)

Hepatic venous pressure gradient: clinical use in chronic liver disease
por: Suk, Ki Tae
Publicado: (2014)

T Cell Subsets and Natural Killer Cells in the Pathogenesis of Nonalcoholic Fatty Liver Disease
por: Gebru, Yoseph Asmelash, et al.
Publicado: (2021)

Diet-Regulating Microbiota and Host Immune System in Liver Disease
por: Eom, Jung A, et al.
Publicado: (2021)

Gut-microbiome Taxonomic Profiling as Non-invasive Biomarkers for the Early Detection of Alcoholic Hepatocellular Carcinoma
por: Seok, Jun, et al.
Publicado: (2020)

Multi-strain probiotics alleviate loperamide-induced constipation by adjusting the microbiome, serotonin, and short-chain fatty acids in rats
por: Jeong, Jin-Ju, et al.
Publicado: (2023)

Scientific Prospects for Cannabis-Microbiome Research to Ensure Quality and Safety of Products
por: Vujanovic, Vladimir, et al.
Publicado: (2020)

Drug-induced liver injury: present and future
por: Suk, Ki Tae, et al.
Publicado: (2012)

Pathway-Based Integrative Analysis of Metabolome and Microbiome Data from Hepatocellular Carcinoma and Liver Cirrhosis Patients
por: Kim, Boram, et al.
Publicado: (2020)

Metabolomics and Microbiomes as Potential Tools to Evaluate the Effects of the Mediterranean Diet
por: Jin, Qi, et al.
Publicado: (2019)

Integrative Analysis of Metabolome and Microbiome in Patients with Progressive Alcohol-Associated Liver Disease
por: Gao, Bei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mkp527pohk8bhkrpgbjki9il54